| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/04/1997 | US5607970 Glycerol monostearate or palmitate |
| 03/04/1997 | US5607960 Indole derivatives as 5-HT1-like agonists for use in migraine |
| 03/04/1997 | US5607959 Analgesics |
| 03/04/1997 | US5607957 Containing also indole, benzofuran, benzthiophene or indazole moiety; method for treatment and/or prevention of clinical conditions for which a selective agonist of 5-ht1-like receptors is indicated |
| 03/04/1997 | US5607952 Substituted 4-phenylthiazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/04/1997 | US5607944 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparations |
| 03/04/1997 | US5607936 Useful in treatment of respiratory diseases |
| 03/04/1997 | US5607931 1,2-disubstituted ethly amides as inhibitors of ACAT |
| 03/04/1997 | US5607915 Pulmonary delivery of active fragments of parathyroid hormone |
| 03/04/1997 | US5607692 Mixture of two lipid vesicle dispersions: first for deep layer treatment has anti- or de-pigmenting agent or tyrosinase inhibitor; second for surface layer treatment has keratolytic, moisturizing or protective agent |
| 03/02/1997 | CA2184570A1 Therapeutic agents for use in cancer therapy |
| 02/27/1997 | WO1997007334A1 Axial flow valve system for linear compressor |
| 02/27/1997 | WO1997007233A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007135A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 02/27/1997 | WO1997007120A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists |
| 02/27/1997 | WO1997007116A1 Prolylendopeptidase inhibitors |
| 02/27/1997 | WO1997007115A1 Benzenesulphonamide derivatives as bradykinine antagonists |
| 02/27/1997 | WO1997007098A1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
| 02/27/1997 | WO1997006826A1 Gene therapy using ovine adenoviral vectors |
| 02/27/1997 | WO1997006813A1 Mucosal preparation containing physiologically active peptide |
| 02/27/1997 | WO1997006805A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 02/27/1997 | WO1997006802A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 02/27/1997 | WO1997006790A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | WO1997006659A2 Use of an eriobotrya japonica extract |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | DE19530868A1 Kapseln, enthaltend gefriergetrocknete, gepulverte grüne Teeblätter Capsules containing freeze-dried, powdered green tea leaves |
| 02/27/1997 | CA2235677A1 Prolylendopeptidase inhibitors |
| 02/27/1997 | CA2229557A1 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 02/27/1997 | CA2229287A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229135A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | CA2226735A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 02/26/1997 | EP0759468A1 Feline interleukin-4 |
| 02/26/1997 | EP0759432A1 Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a skin-related condition |
| 02/26/1997 | EP0759294A2 Hypercholesterolemia therapeutic agent |
| 02/26/1997 | EP0759292A1 Use of alpha type melanocytes stimulating hormone derivatives to stimulate the hairgrowth |
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0759082A1 Dna construct for effecting homologous recombination and uses thereof |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0759027A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 02/26/1997 | EP0758902A1 Compositions and treatment for multiple sclerosis |
| 02/26/1997 | EP0758899A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
| 02/26/1997 | EP0758894A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 02/26/1997 | EP0758893A1 Potentiated antibiotic composition |
| 02/26/1997 | EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
| 02/26/1997 | EP0758891A1 HALOMETHYL AMIDES AS IL-1$g(b) PROTEASE INHIBITORS |
| 02/26/1997 | EP0758890A1 Use of no scavengers, inhibitors or antagonists in the treatment of migraine |
| 02/26/1997 | EP0758887A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 02/26/1997 | EP0758882A1 Methods of lightening hyperpigmented regions in mammalian skin |
| 02/26/1997 | EP0726911A4 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 02/26/1997 | EP0707581B1 Indoline derivatives as 5ht2c antagonists |
| 02/26/1997 | EP0705266B1 Process for producing imidazole derivative |
| 02/26/1997 | EP0587819B1 Medetomidine preparations for transdermal administration |
| 02/26/1997 | CN1143963A Tetracyclic derivatives, process of preparation and use |
| 02/26/1997 | CN1143960A Heterocyclic compound for treatment |
| 02/26/1997 | CN1143953A Certain fused pyrrolecarboxanilides; new class of gaba brain receptor ligands |
| 02/26/1997 | CN1143907A Pharmaceutical compositions |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1143647A Dipeptides which promote release of growth hormone |
| 02/26/1997 | CN1143644A N-|(1,4-diazadicyclo |2,2,2¨ oct -2-yl methyl¨ benzoic amide derivatives, its preparing process and medicinal use |
| 02/26/1997 | CN1143642A New indole, indazole and benzisoxazole compounds, their process of preparation and pharmaceutical compositions which contain them |
| 02/26/1997 | CN1143632A Fluorine-containing benzoylguanidines |
| 02/26/1997 | CN1143628A N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
| 02/26/1997 | CN1143521A Narcotic Chinese patent drug |
| 02/26/1997 | CN1034123C Calcium channel blocking polypeptides from filistate hibernalis |
| 02/25/1997 | US5606065 Antagonist of neurokinin receivers |
| 02/25/1997 | US5606062 Stereoselective reduction |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5606024 Canine G-CSF polypeptides and pharmaceutical compositions comprising same |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605933 Retinoid conjugate compounds and methods for treating of skin aging |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605929 Methods and compositions for inhibiting 5α-reductase activity |
| 02/25/1997 | US5605927 Treatment of skin diseases using ginkgolide PAF antagonists |
| 02/25/1997 | US5605924 Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophenes |
| 02/25/1997 | US5605919 Prevention of cell injury |
| 02/25/1997 | US5605909 Substituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compounds |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605696 Drug loaded polymeric material and method of manufacture |
| 02/25/1997 | US5605688 Recombinant dog and horse type I interferons |
| 02/25/1997 | CA2183937A1 Alkenyl-benzoylguanidine derivatives |
| 02/25/1997 | CA2090509C Process for preparing fibrinogen receptor antagonists |
| 02/25/1997 | CA2046146C Pyrrole derivatives |
| 02/25/1997 | CA1338937C Process for the manufacture of novel substituted alkanediphosphonic acids |
| 02/25/1997 | CA1338934C 3-aminomethyl derivatives of indane, indoline and ¬dihydro-benzo|-furane and thiophene |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997006159A1 Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives |
| 02/20/1997 | WO1997006140A1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 02/20/1997 | WO1997005895A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 02/20/1997 | WO1997005894A1 Pharmaceutical composition containing il-10 |
| 02/20/1997 | WO1997005892A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | WO1997005891A1 Use of plasminogene activators to stimulate local bone growth |
| 02/20/1997 | WO1997005878A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005877A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005876A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases |